In vitro activity of the essential oil of Cymbopogon citratus and its major component (citral) on Leishmania amazonensis

Parasitology Research

Volumn 105, Issue 6, 2009, Pages 1489-1496

  Santin, Marta Regina ^a   Dos Santos, Adriana Oliveira ^b   Nakamura, Celso Vataru ^a,b   Dias Filho, Benedito Prado ^a,b   Ferreira, Izabel Cristina Piloto ^a   Ueda Nakamura, Tânia ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CITRAL; CYMBOPOGON CITRATUS EXTRACT; ESSENTIAL OIL;

AMASTIGOTE; ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; LEISHMANIA; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE;

ANIMALS; CELL LINE; CYMBOPOGON; DOSE-RESPONSE RELATIONSHIP, DRUG; INHIBITORY CONCENTRATION 50; LEISHMANIA MEXICANA; MACROPHAGES; MICE; MICROSCOPY; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MONOTERPENES; OILS, VOLATILE;

CYMBOPOGON CITRATUS; LEISHMANIA AMAZONENSIS; POACEAE; PROTOZOA;

EID: 70350222212     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-009-1578-7     Document Type: Article

References (27)

1. Adams RP (2007) Identification of essential oil components by gas chromatography/mass spectrometry; 4th edn. Allured, Carol Stream, Illinois, p 804
2. GO Adegoke BA Odesola 1996 Storage of maize and cowpea and inhibition of microbial agents of biodeterioration using the powder and essential oil of lemon grass (Cymbopogon citratus) Int Biodeterior Biodegrad 37 81 84 10.1016/0964-8305(95)00062-3
3. JP Anthony L Fyfe H Smith 2005 Plant active components-a resource for antiparasitic agents? Trends Parasitol 21 462 468 10.1016/j.pt.2005.08.004 1:CAS:528:DC%2BD2MXhtVWgsb%2FO 16099722 (Pubitemid 41297749)
4. LCA Barbosa UA Pereira AP Martinazzo CRA Maltha RR Teixeira EC Melo 2008 Evaluation of the chemical composition of Brazilian commercial Cymbopogon citratus (D.C.) stapf samples Molecules 13 1864 1874 10.3390/molecules13081864 1:CAS:528:DC%2BD1cXhtFamsbbJ 18794790
5. MM Blanco CARA Costa AO Freire JG Santos Jr M Costa 2009 Neurobehavioral effect of essential oil of Cymbopogon citratus in mice Phytomedicine 16 2-3 265 270 10.1016/j.phymed.2007.04.007 1:CAS:528:DC%2BD1MXkt12qu7k%3D 17561386
6. JB Calixto 2000 Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents) Braz J Med Biol Res 33 179 189 10.1590/S0100-879X2000000200004 1:STN:280: DC%2BD3c7itlyjsw%3D%3D 10657057
7. MDR Camacho JD Phillipson SL Croft PN Solis SJ Marshall SA Ghazanfar 2003 Screening of plant extracts for antiprotozoal and cytotoxic activities J Ethnopharmacol 89 185 191 10.1016/S0378-8741(03)00269-1 1:STN:280: DC%2BD3srjsVShtg%3D%3D 14611881 (Pubitemid 37378193)
8. PB Carvalho EI Ferreira 2001 Leishmaniasis phytotherapy. Nature's leadership against an ancient disease Fitoterapia 72 599 618 10.1016/S0367-326X(01)00301-X 11543959 (Pubitemid 32799262)
9. M Chen SB Christensen J Blom E Lemmich L Nadelmann K Fich TG Theander A Kharazmi 1993 Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania Antimicrob Agents Chemother 37 2550 2556 1:CAS:528:DyaK2cXmvV2hsQ%3D%3D 8109916
10. AC Cunningham 2002 Parasitic adaptive mechanisms in infection by Leishmania Exp Mol Pathol 72 132 141 10.1006/exmp.2002.2418 1:CAS:528: DC%2BD38Xhslyht7s%3D 11890722 (Pubitemid 34941288)
11. P Desjeux 2004 Leishmaniasis: current situation and new perspectives Comp Immunol Microbiol Infect Dis 27 305 318 10.1016/j.cimid.2004.03.004 1:STN:280:DC%2BD2czitl2qtA%3D%3D 15225981 (Pubitemid 38842803)
12. NE Hernández ML Tereschuk LR Abdala 2000 Antimicrobial activity of flavonoids in medicinal plants from Tafí del Valle (Tucumán, Argetina) J Ethnopharmacol 73 317 322 10.1016/S0378-8741(00)00295-6 11025172 (Pubitemid 30750518)
13. C Kanko E Sawaliho S Kone G Koukoua YT N'guessan 2004 Étude des propriétés physico-chimiques des huiles essentielles de Lippia multiflora, Cymbopogon citratus, Cymbopogon nardus, Cymbopogon giganteus C R Chim 7 1039 1049 1:CAS:528:DC%2BD2cXoslSns74%3D
14. E Lewinsohn N Dudai Y Tadmor I Katzir U Ravid E Putievsky DM Joel 1998 Histochemical localization of citral accumulation in lemongrass leaves (Cympobogon citratus (DC.) Stapf., Poaceae) An Bot 81 35 39 10.1006/anbo.1997. 0525 1:CAS:528:DyaK1cXnsFWmuw%3D%3D (Pubitemid 28065643)
15. PS Luize TS Tiuman LG Morello PK Maza T Ueda-Nakamura BPD Filho DAG Cortez JCP Mello CV Nakamura 2005 Effects of medicinal plant extracts on growth of Leishmania (L.) amazonensis and Trypanosoma cruzi Braz J Pharm Sci 41 85 94
16. MJ McConville E Handman 2007 The molecular basis of Leishmania pathogenesis Int J Parasitol 37 1047 1051 10.1016/S0020-7519(07)00216-0 1:CAS:528:DC%2BD2sXnslWgtbk%3D 17629957 (Pubitemid 47044878)
17. SF Melo SF Soares RF Costa CR Silva MBN Oliveira RJAC Bezerra A Caldeira-de-Araujo M Bernardo-Filho 2001 Effect of the Cymbopogon citratus, Maytenus ilicifolia and Baccharis genistelloides extracts against the stannous chloride oxidative damage in Escherichia coli Mutat Res 496 33 38 1:CAS:528:DC%2BD3MXls1eht7w%3D 11551478
18. RB Pedroso T Ueda-Nakamura BP Dias Filho DAG Cortez LER Cortez JA Morgado-Díaz CV Nakamura 2006 Biological activities of essential oil obtained from Cymbopogon citratus on Crithidia deanei Acta Protozool 45 231 240
19. R Puatanachokchai H Kishida A Denda N Murata Y Konishi U Vinitketkumnuen D Nakae 2002 Inhibitory effects of lemon grass (Cymbopogon citratus, Stapf) extract on the early phase of hepatocarcinogenesis after initiation with diethylnitrosamine in male Fischer 344 rats Cancer Lett 183 9 15 10.1016/S0304-3835(02)00111-8 1:CAS:528:DC%2BD38XktFKgs7s%3D 12049809 (Pubitemid 34607346)
20. SMK Rates 2001 Plants as source of drugs Toxicon 39 603 316 10.1016/S0041-0101(00)00154-9 1:CAS:528:DC%2BD3MXotlyr 11072038 (Pubitemid 30799210)
21. CS Rauber SS Guterres EES Schapoval 2005 LC determination of citral in Cymbopogon citratus volatile oil J Pharm Biomed Anal 37 597 601 10.1016/j.jpba.2004.10.042 (Pubitemid 40312307)
22. JCF Rodrigues M Attias C Rodriguez JA Urbina W Souza 2002 Ultrastructural and biochemical alterations induced by 22, 26-azasterol, a Δ24(25)-sterol methyltransferase inhibitor, on promastigote and amastigote forms of Leishmania amazonensis Antimicrob Agents Chemother 46 487 499 10.1128/AAC.46.2.487-499. 2002 1:CAS:528:DC%2BD38XosFyhtA%3D%3D 11796362 (Pubitemid 34087200)
23. RM Santa-Rita A Henriques-Pons HS Barbosa SL Castro 2004 Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis J Antimicrob Chemother 54 704 710 10.1093/jac/dkh380 1:CAS:528:DC%2BD2cXotVyqsLw%3D 15329361 (Pubitemid 39386721)
24. GF Santoro MG Cardoso LGL Guimarães JM Freire MJ Soares 2007 Anti-proliferative effect of the essential oil of Cymbopogon citratus (DC) Stapf (lemongrass) on intracellular amastigotes, bloodstream trypomastigotes and culture epimastigotes of Trypanosoma cruzi (Protozoa: Kinetoplastida) Parasitol 134 1649 1656 1:CAS:528:DC%2BD2sXhtVSgsbnO
25. T Ueda-Nakamura M Attias W Souza 2001 Megasome biogenesis in Leishmania amazonensis: a morphometric and cytochemical study Parasitol Res 87 89 97 10.1007/s004360000319 1:STN:280:DC%2BD3MzmslelsA%3D%3D 11206117 (Pubitemid 32208945)
26. GSB Viana TG Vale RSN Pinho FJA Matos 2000 Antinociceptive effect of the essential oil from Cymbopogon citratus in mice J Ethnopharmacol 70 323 327 10.1016/S0378-8741(99)00168-3 1:CAS:528:DC%2BD3cXjs1Grtrc%3D 10837994 (Pubitemid 30317371)
27. WHO - WORLD HEALTH ORGANIZATION. Leishmaniasis: disease burden and epidemiological trends. Special Programme for Research and Training in Tropical Diseases. Geneva: WHO, 2002. Online: http://www.who.int/tdr/diseases/leish/ files/direction.pdf. Accessed 11 december 2007